With the sword of Damocles transformed into the conclusions of the scientific article advanced on the Internet but that will be published the next 14th in the printed edition of "The New England Journal of Medicine" on the irrigation of heart attacks of the fogmus AntidiaboseAvandia, several thousand research and clinics around the world meet in the American city of Chicago, to attend the scientific sessions of the American Diabetes Association, in their sixty -seven edition.No news is expected over the therapy arsenal against this disease that, according to the United Nations estimates, affects more than two hundred and forty million people in their types 1 and 2. Diabetes has become, according toThe predictions for the immediate future, in a threat and a world epidemis.However, the partners of this scientific work that has recently been made due to its importance for health, will fly over the halls of the Chicago Convention Center.Approximately two million type 2 diabians take this drug, which has been in the world market for eight years and to which scientists "accuse" cardiovascular risk.Type 2 diabetes will focus most of the communications and seminars, since estimates on their incidence in the next twenty years are really alarming: more than three hundred million affected.

The expected scientific intervention of this meeting is that of Francis Collins, director of the National Institute for the United States Human Genome, that he will talk about the gene identification of diabetes susceptibility.This researcher dictated atoms, in Madrid, the commemorative lecion of the Conchita Ranbano Foundation of Jimã © Nez Dãaz, currently works on the geniical causes of type 2 diabetes.

As well as explained in various forums there are at least ten variations in the genomaj that raise the risk of diabetes.It should be remembered that Collins, prize of Asturias of research, identified the gene of endocrine neoplasia mãºltiple and has performed extensive bysques in the population of Finland of the genes they produce in the sensitivity to diabetes.

ARTICLE PUBLISHED 9/6/7 IN ABC